Luye Pharma Group Stock Filter Stocks by Fundamentals
| LYPHF Stock | USD 0.34 0.00 0.00% |
Luye Pharma Group fundamentals help investors to digest information that contributes to Luye Pharma's financial success or failures. It also enables traders to predict the movement of Luye Pink Sheet. The fundamental analysis module provides a way to measure Luye Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Luye Pharma pink sheet.
Luye |
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Luye Fundamentals
| Return On Equity | -0.0261 | |||
| Return On Asset | 0.0081 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 2.08 B | |||
| Shares Outstanding | 3.55 B | |||
| Shares Owned By Insiders | 35.41 % | |||
| Shares Owned By Institutions | 24.08 % | |||
| Price To Book | 2.17 X | |||
| Price To Sales | 0.47 X | |||
| Revenue | 5.2 B | |||
| Gross Profit | 3.4 B | |||
| EBITDA | 324.9 M | |||
| Net Income | (134.39 M) | |||
| Total Debt | 4.21 B | |||
| Debt To Equity | 1.15 % | |||
| Current Ratio | 1.46 X | |||
| Book Value Per Share | 2.54 X | |||
| Cash Flow From Operations | 182.37 M | |||
| Earnings Per Share | 0.03 X | |||
| Number Of Employees | 4.8 K | |||
| Beta | 0.93 | |||
| Market Capitalization | 2.66 B | |||
| Total Asset | 22.58 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 22.58 B |
About Luye Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Luye Pharma Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Luye Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Luye Pharma Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Luye Pink Sheet
Luye Pharma financial ratios help investors to determine whether Luye Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Luye with respect to the benefits of owning Luye Pharma security.